Status:
COMPLETED
Study of the Link Between Psychosocial Treatments and the Need of Pharmacological Treatments in Children With Attention Deficit Hyperactivity Disorder
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Attention Deficit Hyperactivity Disorder
Youths
Eligibility:
All Genders
6-18 years
Brief Summary
The Attention Deficit and Hyperactivity Disorder (ADHD) is a frequent disorder in children and adolescents. The diagnosis is clinical with the input of several informants (child, family, teachers, …)....
Eligibility Criteria
Inclusion
- Inclusion criteria:
- \- Children 6-18 years of age, diagnosed with ADHD, treated with methylphenidate for at least 6 months. Parents' online response between may and june 2020.
- Exclusion criteria:
- \- Exclusion of respondants not caring for the child , refusal to participate
Exclusion
Key Trial Info
Start Date :
May 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2020
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT04412499
Start Date
May 1 2020
End Date
June 30 2020
Last Update
July 29 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uhmontpellier
Montpellier, France, 34295